We also provide evidence supporting a role for UGDH in hepatocytes as a robust suppressor of RIPK1-driven NASH-associated liver damage that functions to resolve hepatocellular death and fibrosis. This evidence concerns the gene RIPK1 and metabolic dysfunction-associated steatohepatitis.